As drugmakers push prices higher, some are attacking employers and payers that offer prescription drug coverage, writes John Jones, professor of pharmacy law and ethics. "When it comes to how high drug companies price their products, they want the public to ignore what they spend on marketing and the tax breaks they get for direct-to-consumer advertising," Jones writes.
A draft executive order instructs agencies to review policies that could raise the cost of pharmaceutical research and development and to recommend policy changes in fiscal 2019 budget proposals. The draft instructs trade negotiators to seek deals that increase the prices other countries pay for American prescription drugs.
A Senate health care bill would phase out Medicaid expansion and limit federal funding for the program, eliminate the Affordable Care Act's health insurance mandate, offer lower tax credits than the ACA, repeal some taxes and retroactively reduce capital gains taxes, among other measures.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications